ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. The 10 years discounted cash flows model indicates that the company's stock is currently undervalued at between $4.39 and $5.64 (26.9% - 63%) Technical analysis indicates that bulls have oversaturated the market and we...
Approach this with extra-care, allocate less than usual, and take profit fast. This is a penny stock and a high-risk / high-reward scenario. Clear 6-month uptrend Support with a Bullish Pennant formed within. Target price set at a new potential resistance line. I suggest entering a Buy Stop order. If the stop price is not triggered, I wouldn't try to chase a...
It's been 2 years since $ATRS was last above $4 a share. Might be some fireworks next week. Antares Pharma, Inc. (ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019 at 12:00 p.m. Eastern Time. About Antares Pharma Antares Pharma,...
Sitting at a crucial point now. Current range in between 2.4 - 2.5. Reversal might happen however signal appears to be weakish, would like a strong confirmation tomorrow If ATRS breaks below the range, it's going to have a hard time coming back up
ATRS has broken the uptrend with a strong impulse. I'm looking for a potential bounce before one more wave down. Bearish divergence on 4h chart.
$ATRS not my typical play but recent insiders and fairly high short interest Settlement Date Short Interest Avg Daily Share Volume Days To Cover 3/15/2016 10,444,826 866,786 12.050063